Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 4424
118th Congress(2023-2024)
Vietnam Veterans Liver Fluke Cancer Study Act
Active
Active
Passed House on Sep 17, 2024
Overview
Text
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 4424 (Reported-in-House)

Union Calendar No. 500

118th CONGRESS
2d Session
H. R. 4424

[Report No. 118–600]


To direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

June 30, 2023

Mr. LaLota (for himself, Mr. Ryan, Mr. Fitzpatrick, Mr. Case, and Ms. Spanberger) introduced the following bill; which was referred to the Committee on Veterans' Affairs

July 22, 2024

Additional sponsors: Mr. Davis of North Carolina, Mr. Garbarino, Mr. Lawler, Mr. Kildee, Ms. Kuster, Mr. Deluzio, Mr. Kilmer, Ms. Lofgren, Ms. Perez, Ms. Blunt Rochester, Mr. Gottheimer, and Mr. Ciscomani

July 22, 2024

Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed

[Strike out all after the enacting clause and insert the part printed in italic]

[For text of introduced bill, see copy of bill as introduced on June 30, 2023]

A BILL

To direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Vietnam Veterans Liver Fluke Cancer Study Act”.

SEC. 2. Study on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era.

(a) Epidemiological study.—Not later than 120 days after the date of enactment of this Act, the Secretary of Veterans Affairs, in consultation with the Director of the Centers for Disease Control and Prevention of the Department of Health and Human Services, shall commence an epidemiological study on the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era, using data from the Veterans Affairs Central Cancer Registry and the National Program of Cancer Registries. The study shall—

(1) identify the rate of incidence of cholangiocarcinoma in covered veterans of the Vietnam era and in residents of the United States, from the beginning of the Vietnam era to the date of enactment of this Act; and

(2) for each of the groups specified in paragraph (1), identify the percentage of individuals with cholangiocarcinoma by various demographic characteristics, including by age, gender, race, ethnicity, and the geographic location of the patient at the time of diagnosis.

(b) Report to Congress.—Not later than one year after the completion of the study under subsection (a), the Secretary shall submit to Congress a report containing—

(1) the results of the study under subsection (a); and

(2) recommendations for administrative or legislative actions required to address issues identified in the study under subsection (a).

(c) Continued tracking of cholangiocarcinoma in covered veterans of the Vietnam era.—The Secretary shall track the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era using the Veterans Affairs Central Cancer Registry, and provide such information to Congress as required under subsection (d).

(d) Follow-Up reports.—The Secretary shall periodically submit to the Congress an updated report under subsection (b), as determined by the Secretary.

(e) Definitions.—In this section:

(1) The term “Secretary” means the Secretary of Veterans Affairs.

(2) The term “Vietnam era” has the meaning given such term in section 101 of title 38, United States Code.

(3) The term “covered veterans of the Vietnam era” means veterans who served in the Vietnam theater of operations during the Vietnam era.

SEC. 3. Modification of certain housing loan fees.

The loan fee table in section 3729(b)(2) of title 38, United States Code, is amended by striking “November 15, 2031” each place it appears and inserting “November 29, 2031”.

Union Calendar No. 500

118th CONGRESS
     2d Session
H. R. 4424
[Report No. 118–600]
A BILL
To direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era, and for other purposes.
July 22, 2024
Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed